pacemakers, and the Visionist and Valitude cardiac resynchronization therapy pacemakers. Neil Guckian, Director of Finance for the Western Trust. DER0920-103KM “While the recall by Boston ...

The CONTAK study randomised, in a double-blind fashion, 490 patients with heart failure, left ventricular ejection fraction ⩽35% and QRS ⩾120 msec who required an implantable cardiac defibrillator ...

Brookstone Capital Management lifted its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the ...

Background: Prior studies of cardiac rhythm management devices (pacemakers [PM] and implantable cardioverter defibrillators [ICD]) utilization in the United States have been limited to the ...

Salem Investment Counselors Inc. trimmed its position in Medtronic plc (NYSE:MDT – Free Report) by 17.1% in the fourth ...

Morgans analyst Scott Power said investors have dealt with Avita Medical "fairly harshly" after it downgraded its earnings ...

Absent or delayed therapy may be caused by programmed values (including human error), ICD system performance, or a combination of the two. The most common causes are ICD inactivation, VT slower ...

Dec. 12, 2024 — Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular ...